Ingen Technologies Announces the Appointment of Gary Tilden as Chief Operating Officer and Chairman
YUCAIPA, CALIFORNIA, March 9, 2011 (OTC Disclosure & News Services) -- Ingen Technologies (IGNT) is pleased to announce the appointment of Gary Tilden to the position of Chief Operating Officer, effective February 14, 2011. Mr. Tilden will be based at the Company's California office where he will be responsible for all Company operational activities, and in particular will oversee the manufacturing and engineering of the company's respiratory products.
A veteran of the tooling and automation manufacturing equipment industry, Mr. Tilden holds 30 years of experience incorporate operations and manufacturing. His success as a business owner involved the design and development of the island hood stack mounting system for Imperial Cal Products. Mr. Tilden operated his own businesses for 20 years and holds several certifications in various fabrications. He held management positions with Jefco Manufacturing and Aristokraft Cabinetries, a subsidiary of Fortune Brands. He will be the spokesperson of the Company in California and will help to establish the Ingen brand with employees and distributors.
"The company is on track and positioned to move forward in the medical industry with its new vision and new management." Stated Gary Tilden, COO. "We are pleased to have resolved several problems that are now behind us. Mr. Tilden has proven that he can move this company where it belongs. Over the past several years Ingen has invested valuable time and resources to become a medical device manufacturer with proprietary and patented medical products that are now branded in the respiratory industry. With many new opportunities in the export and government sectors, Ingen's new management is capable of securing the growth and market acceptance of its product line through strategic partnerships currently under negotiations." Stated Thomas Neavitt, CEO.
About Ingen:
Ingen, a wholly owned subsidiary of the public company, is an ISO 13485:2003 Certified Medical Device Manufacturer with an emerging new medical product line for the respiratory market. This industry is worth an estimated $4 Billion in the US, and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing US and Foreign Patents, including a successful registration with the Food & Drug Administration. The company is establishing domestic and global distribution with manufacture representative organizations, and OEM partners. In 2009 the SMART Nasal Cannula using the Oxyview Technology was introduced as the world's first oxygen cannula with an in-line pneumatic oxygen flow meter. In 2010 the company introduced its new INGEN Pulse Oximeter.
Safe Harbor for Forward-LookingStatements: This news release includes forward-looking statements. For example, when we say that we havequotes out for $400,000 in product, and will update shareholders on productsales over the next few weeks, we are using forward-looking statements. [M R1] While thesestatements are made to convey to the public the company’s progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management’s opinion. Where as management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company’s operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company’s periodic filings with the U.S.Securities and Exchange Commission.
CONTACT: Gary Tilden,Chairman & COO
Ingen Technologies, Inc.
35193Avenue A
Yucaipa,CA 92399
(909)790-7180
(909)790-7185 FAX
info@ingen-tech.com
www.ingen-tech.com
[M R1]Thiscan be in here for this release or not, it's your call.